-+ 0.00%
-+ 0.00%
-+ 0.00%

The FDA plans to overhaul the rare disease review process under new leadership.

智通財經·10/14/2026 13:09:16
語音播報
The FDA plans to overhaul the rare disease review process under new leadership.